Atlas Trials

Compassionate Use of Metreleptin in Previously Treated People With Partial Lipodystrophy

Clinical trial NCT02262806 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT02262806
Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
DiabetesLipodystrophyHyperlipidemia
Start date
2014-10-14
Primary completion
2027-07-31
Enrollment
29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.